Trials / Conditions / Amyloidosis; Systemic
Amyloidosis; Systemic
8 registered clinical trials studyying Amyloidosis; Systemic — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Essen Amyloidosis Registry NCT06887283 | University Hospital, Essen | — |
| Recruiting | Optimize First-line Treatment for AL Amyloidosis With t (11; 14) NCT06192979 | Jin Lu, MD | N/A |
| Recruiting | A Study of AT-02 in Subjects With Systemic Amyloidosis. NCT05951049 | Attralus, Inc. | Phase 2 |
| Recruiting | Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis NCT05521022 | Attralus, Inc. | Phase 1 |
| Completed | A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis NCT05201911 | Attralus, Inc. | Phase 1 |
| Unknown | Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis NCT04474938 | Peking Union Medical College Hospital | Phase 2 |
| Completed | BCD With or Without Doxycycline in Mayo Stage II-III Light Chain Amyloidosis Patients NCT03401372 | Jian Li | N/A |
| Terminated | Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients NCT02994784 | Boston Medical Center | Phase 2 |